STOCK TITAN

Sila Realty Trust Inc SEC Filings

SILA NYSE

Welcome to our dedicated page for Sila Realty Trust SEC filings (Ticker: SILA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Locating lease expirations, funds-from-operations calculations, and dividend coverage inside Sila Realty Trust’s filings can feel like sorting through hospital blueprints. With properties spread across medical office buildings and specialty hospitals, every disclosure packs property-level rent rolls and regulatory details. The result is a 10-K that rivals a textbook and a steady flow of 8-K updates after each acquisition. Investors searching for “Sila Realty Trust SEC filings explained simply” need more than raw PDFs—they want insight.

Stock Titan delivers that insight. Our platform pulls every form the moment it hits EDGAR and feeds it through AI that highlights the metrics that matter. If you’re hunting for “Sila Realty Trust insider trading Form 4 transactions,” we not only flag the filing but translate the codes so you see who bought, who sold, and how many shares. Want the “Sila Realty Trust quarterly earnings report 10-Q filing” without the boilerplate? Our AI summary isolates rent growth, normalized FFO, and coverage ratios in minutes.

  • Sila Realty Trust annual report 10-K simplified – understand property mix, lease maturities, and dividend sustainability.
  • Sila Realty Trust 8-K material events explained – quick briefs on acquisitions, tenant changes, or credit amendments.
  • Sila Realty Trust proxy statement executive compensation – compare CEO pay to FFO performance.
  • Sila Realty Trust Form 4 insider transactions real-time – immediate alerts on executive moves.

Whether you’re modelling net operating income trends or benchmarking capital allocation, our AI-driven commentary provides “Sila Realty Trust earnings report filing analysis” that puts each number in context. Use it for scenario planning, credit evaluation, or simply “understanding Sila Realty Trust SEC documents with AI.” Professionals monitor “Sila Realty Trust executive stock transactions Form 4” to gauge management conviction; income investors track dividend coverage before each quarter closes. Whatever your goal, Stock Titan lets you move from disclosure to decision without wading through annexes.

Rhea-AI Summary

Schedule 13G Overview – The Vanguard Group & Ralliant Corp (RAL)

On 30 June 2025, The Vanguard Group filed a Schedule 13G reporting passive beneficial ownership of Ralliant Corp’s common stock. Vanguard now controls 13,174,096 shares, representing 11.65 % of RAL’s outstanding shares. The filing is made under Rule 13d-1(b) because Vanguard is an SEC-registered investment adviser ("IA").

Voting vs. dispositive authority

  • Sole voting power: 0 shares
  • Shared voting power: 49,118 shares
  • Sole dispositive power: 12,898,650 shares
  • Shared dispositive power: 275,446 shares

While Vanguard has virtually no direct voting power, it retains the right to dispose of nearly all of the reported shares, indicating the holding is spread across indexed and managed funds that delegate voting to third parties or follow fund-level policies.

Implications for investors

  • Crossing the 10 % threshold makes Vanguard a significant institutional holder, potentially increasing RAL’s visibility among passive and ETF-tracking investors.
  • The passive 13G filing (rather than an activist 13D) signals no intention to influence control or strategy.
  • Concentrated ownership may add liquidity support but could create share-supply risk if Vanguard trims its position.

The certification confirms the stake was acquired in the ordinary course of business and not to influence management. The document is signed by Ashley Grim, Head of Global Fund Administration, on 7 July 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

JPMorgan Chase Financial Company LLC is offering Leveraged Market-Linked Step Up Notes maturing in July 2027 that are linked to a six-index international equity basket. The basket is weighted 40% EURO STOXX 50, 20% FTSE 100, 20% Nikkei 225, 7.5% Swiss Market Index, 7.5% S&P/ASX 200 and 5% FTSE China 50, making European performance—particularly the EURO STOXX 50—the largest driver of returns.

Return profile at maturity

  • If the basket is flat or higher, holders receive the greater of: (a) principal plus a Step Up Payment of 16–18% ($1.60–$1.80 per $10 unit) or (b) principal plus 150% of the positive basket return.
  • If the basket declines, investors incur a 1-for-1 loss of principal—up to total loss—based solely on the final basket level.
No interim coupons are paid.

Key structural terms

  • Denomination: $10 per unit; minimum initial order of 10,000 units.
  • Tenor: approximately 2 years.
  • Issuer credit: unsecured note of JPMorgan Chase Financial Company LLC; fully and unconditionally guaranteed by JPMorgan Chase & Co.
  • Fees: $0.20 per unit (sales commission $0.15; structuring fee $0.05).
  • Initial estimated value: $9.50–$9.715, below the $10 public offering price due to embedded fees and internal funding assumptions.
  • Secondary market: none expected; JPMS may offer limited, uncommitted liquidity.

Risk highlights

  • Full downside market exposure with no principal protection.
  • Performance measured only on the Final Calculation Day; interim gains can be lost.
  • Credit risk of both issuer and guarantor; notes are not FDIC-insured.
  • Potential conflict of interest as JPMS is calculation agent and hedging counterparty.
  • Estimated value discount and fees create negative carry for investors exiting early.

The product suits investors with a bullish or neutral two-year view on the basket who can tolerate full loss of principal, forgo dividends and accept limited liquidity in exchange for enhanced upside participation and a defined minimum positive return.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Lightwave Logic, Inc. (LWLG) Form 4 filing: Director Craig Ciesla was granted 80,645 restricted stock units (RSUs) on 06/30/2025 under the company’s 2025 Equity Incentive Plan at $0.00 exercise price. The award vests in four tranches: 20,162 RSUs on 07/15/2025 and 20,161 RSUs on each of 09/30/2025, 12/31/2025 and 03/31/2026, contingent on continued service. Following the grant, Ciesla’s total beneficial ownership equals 80,645 RSUs, all held directly. No common shares were sold or disposed of, so the filing signals no insider selling pressure. While the grant is non-cash and non-dilutive until vested and settled, the shares will add modest dilution when they convert to common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

GS Finance Corp. is offering $1.08 million of Autocallable Contingent Coupon Equity-Linked Notes due 2028, fully and unconditionally guaranteed by The Goldman Sachs Group, Inc. The notes are tied to the performance of Palantir Technologies Inc. (PLTR) Class A common shares and form part of Goldman’s Series F medium-term note program.

Key commercial terms

  • Face amount: $1,000 per note (aggregate $1.08 million)
  • Issue price: 100% (trade date 30-Jun-2025; settlement 03-Jul-2025)
  • Quarterly contingent coupon: $69.625 (6.9625% per quarter, up to 27.85% p.a.) payable only if PLTR closes at or above 60% of the initial price ($136.32) on the relevant observation date.
  • Automatic call: If PLTR closes at or above the initial price on any quarterly call observation date from Sep-2025 to Mar-2028, the notes are redeemed at par plus the due coupon.
  • Downside protection: 40% buffer. If the final price on 30-Jun-2028 is ≥60% of the initial price, holders receive par plus any final coupon. If below 60%, repayment equals par plus (index return × par), exposing investors to full downside beyond the buffer.
  • Estimated value at pricing: ~$970 per $1,000, reflecting structuring fees and dealer margin; underwriting discount 2%.
  • Secondary market: GS & Co. may, but is not obliged to, make a market; bid/ask reflects estimated value plus declining premium (initially $25).
  • Credit: senior unsecured obligation of GS Finance Corp. with unconditional guarantee from The Goldman Sachs Group, Inc.; not FDIC insured.

Risk highlights

  • Investors may receive no coupons if PLTR trades below the 60% trigger on observation dates.
  • If PLTR falls >40% at maturity and the note hasn’t been called, principal loss is one-for-one with the stock’s decline.
  • Limited upside: maximum redemption is par plus due coupon; investors do not participate in stock gains above par.
  • Market value likely to be below issue price; liquidity limited; pricing sensitive to GS credit spreads, PLTR volatility and interest rates.
  • Product complexity, dilution events, market disruption adjustments and discretionary determinations by GS & Co. add additional risks.

The prospectus supplement also details anti-dilution adjustments, default provisions, tax characterization (income-bearing prepaid derivative contract) and extensive hypothetical scenarios illustrating coupon and principal outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

OCI N.V. and its Dutch subsidiaries OCI Intermediate B.V. and OCI Chemicals B.V. have filed a Schedule 13G disclosing a sizeable passive stake in Methanex Corporation (NASDAQ/TSX: MEOH). The filing, triggered by a June 27 2025 event date, shows beneficial ownership of 9,944,308 common shares, equal to 12.9 % of Methanex’s 77,339,520 shares outstanding as of June 30 2025.

All shares are held with shared voting power over 7,726,218 shares – subject to an undertaking not to vote more than 9.99 % of the company’s outstanding stock until Toronto Stock Exchange listing conditions are satisfied – and shared dispositive power over the full 9.94 million-share position. The reporting persons possess no sole voting or dispositive authority, underscoring the filing’s passive intent. Each entity certifies that the securities were not acquired for the purpose of influencing control, in line with Schedule 13G requirements.

The disclosure makes OCI – a Netherlands-based global producer of nitrogen, methanol and hydrogen products – one of Methanex’s largest known shareholders. While the filing does not announce any transaction terms or strategic plans, the scale of the stake (worth roughly US$450-500 million at recent prices) signals institutional confidence in Methanex’s methanol market outlook and could foreshadow future collaboration or corporate activity within the global methanol value chain.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Novanta Inc. (NASDAQ: NOVT) entered into a Fourth Amended & Restated Credit Agreement on 27 June 2025 that replaces its 2019 facility scheduled to mature in March 2027. The new agreement provides an aggregate senior secured credit capacity of approximately US$1.0 billion, broken down into:

  • €65.31 million 5-year Euro-denominated term loan
  • $75 million 5-year US-dollar term loan
  • $850 million 5-year revolving credit facility

The maturity is extended to June 2030, and an uncommitted accordion feature can raise total commitments by an additional $350 million, subject to customary conditions. Interest is set at (i) Base Rate + 0–0.75 ppt or (ii) SOFR/SONIA/EURIBOR + 1.00–1.75 ppt, with pricing tied to the company’s consolidated leverage ratio. A commitment fee applies to unused revolver capacity.

Key financial covenants tested quarterly include: (1) maximum consolidated leverage ratio of 3.5× (step-up to 4.0× for four quarters following qualifying acquisitions >= $50 million) and (2) minimum fixed-charge coverage ratio of 1.25×. The facilities are secured by senior liens on substantially all assets of Novanta and certain subsidiaries and contain customary negative covenants on mergers, asset sales, indebtedness, investments and liens.

Required quarterly principal amortization begins September 2025 for the Euro term loan and September 2026 for the US term loan, with final balloon payments due at maturity. Prepayments from asset sales, casualty events or incremental debt are mandatory, while voluntary prepayments and commitment reductions are permitted without premium.

Outstanding borrowings under the prior facility were $392.4 million as of 28 March 2025. The new structure enhances liquidity headroom, extends tenor, and provides interest-rate optionality, but also secures the debt and maintains leverage limits that investors should monitor.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Sila Realty Trust (SILA)?

The current stock price of Sila Realty Trust (SILA) is $23.71 as of July 11, 2025.

What is the market cap of Sila Realty Trust (SILA)?

The market cap of Sila Realty Trust (SILA) is approximately 1.3B.

What type of assets does Sila Realty Trust Inc invest in?

Sila Realty Trust Inc primarily invests in healthcare properties, including various types of medical facilities that are essential for long-term operational stability.

How does the company generate its revenue?

The company generates revenue through rental income and other returns stemming from its portfolio of healthcare real estate investments, ensuring a stable cash flow structure.

What is the core focus of Sila Realty Trust Inc's business model?

The core focus is on acquiring, managing, and optimizing healthcare assets to provide consistent cash distributions to stockholders while preserving and returning invested capital.

How does Sila Realty Trust Inc ensure capital preservation?

Capital preservation is achieved through careful asset selection, diligent property management, and a disciplined investment strategy that emphasizes long-term financial stability.

What distinguishes Sila Realty Trust Inc from other REITs?

Its specialized focus on healthcare real estate, thorough operational protocols, and commitment to regular cash distributions differentiate it from broader-based REITs.

Who might consider investing in Sila Realty Trust Inc?

Investors looking for income-generating assets in a specialized market segment, particularly those interested in the stability offered by healthcare-related real estate investments, may find it appealing.

What role does asset management play in the company's strategy?

Asset management is central to its strategy, as it involves the continuous evaluation, integration, and oversight of healthcare properties to ensure they meet operational and financial objectives.
Sila Realty Trust Inc

NYSE:SILA

SILA Rankings

SILA Stock Data

1.32B
54.61M
0.89%
56.87%
2.87%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
TAMPA